The monoclonal antibody CL21 recognizes a determinant present on 
INTRODUCTION
The Xenopus embryo is a unique model for studying early development of the hematopoietic and immune systems. Extensive study has shown that many aspects of the Xenopus hematopoietic and immune systems are similar to those of more recent vertebrates (Du Pasquier et al., 1989) .
Additionally, Xenopus embryos are accessible to experimental intervention at all developmental stages, making in vivo, physiological studies of the earliest events in hematopoietic differentiation possible.
In order to examine the parameters involved in stem-cell development in more detail, we have removed lateral plate mesoderm from stage 20 Xenopus embryos and placed it in culture (Turpen and Smith, 1985 (35-200 kD) . Therefore, it was important to establish whether mAbs CL21 and XL-1 recognize the same determinant. Figure 5 shows the results of an experiment in which thymocytes and splenocytes were radiolabeled with 125I and surface molecules were analyzed using these two antibodies. Immunoprecipitations from thymus and spleen using mAb XL-1 are shown in lanes a and g. Under (Turpen and Smith, 1985 (Thomas, 1989) .
Members of the CD45 family make up approximately 10% of the molecules on the lymphocyte surface and contain much of the carbohydrate moieties expressed by lymphoid cells (Tonks et al., 1989) . Lymphocyte subpopulations can be delineated on the basis of distinct CD45 isoforms recognized by different monoclonal antibodies (Smith et al., 1986) . Moreover, during maturation of prothymocytes to mature T cells, there is developmentally regulated expression of CD45 family members (Lefrancois and Goodman, 1987) . For these reasons, we wanted to compare the antigens recognized by mAb CL21 with the putative leukocyte common antigen recognized by mAb XL-1 (Ohinata et al., 1989 Depending on conditions, antibodies to CD45 have been shown to either augment or inhibit Tcell proliferation (Pingel and Thomas, 1989; Thomas, 1989; Samelson et al., 1990 (Lansdorp et al., 1990 
MATERIALS AND METHODS

Animals
Gravid female Xenopus were initially obtained from commercial suppliers (Xenopus I, Ann Arbor, MI; Carolina Biological Supply, Burlington, NC) and have been repeatedly bred in the laboratory. All animals used in these studies were derived from outbred embryos fertilized in the laboratory and reared under optimal conditions. Postmetamorphic juveniles were at least 6 months of age.
Preparation of Monoclonal Antibodies
Immunogens. Peripheral blood and thymuses were removed from juvenile frogs, washed, and stored at 4C over night in amphibian phosphatebuffered saline (APBS) containing 0.5% BSA.
Plasma membranes were prepared according to the dextranpolyethylene glycol aqueous twophase system of Brunette and Till (1971) . Briefly, 50 g of 20% dextran (w/w); 25.75 g of 30% PEG (w/w); 24.75ml distilled water; 83.25ml of 0.22 M phosphate buffer, pH 6.5; and 20 ml of 10-2M ZnCI2 were mixed in a separatory funnel and allowed to separate at 4C. Cell suspensions were washed once in APBS, suspended in 10-3M ZnCI2, and incubated 30 min at 4C. Cells were gently ruptured on ice using a 7ml Dounce homogenizer with pestel A (800-1000 strokes). The resulting homogenate was pelleted (10,000 X G) and suspended in 1.5 ml of the top phase of the separating system. 1.5 ml of the bottom phase was added, the phases were mixed and centri-fuged at 10,000xG for 10min in a fixed-angle rotor using an IEC model B200 high-speed centrifuge. The plasma membranes, confirmed by electron microscopy of erythrocyte preparations (data not shown), were concentrated at the interface between the two phases and the nuclei were found in the pellet. The interface was collected, diluted fourfold with distilled water, and the membranes were pelleted by an additional centrifugation at 10,000xG for 10 min. The final membrane pellet was suspended in mammalian saline.
Immunization. In order to tolerize mice to Xenopus erythrocyte cell-surface determinants, 3-month-old Balb/c mice were injected subcutaneously with purified membranes from 108 erythrocytes emulsified in complete Freund's adjuvant (CFA) . Three days following the immunization, mice were injected with 150mg/kg cyclophosphamide, delivered in three equal doses at 2-day intervals (Matthew and Patterson, 1983 (Flajnik et al., 1984; Kauffman et al., 1985 150 mM NaC1; and 0.5% Triton-X-100) and boiled 4 min in Laemmli sample buffer (Laemmli, 1970) . Both reduced and nonreduced samples were run on 5-15% NaDodSO4 polyacrylamide gels. (Turpen and Smith, 1985) .
Metabolic activation. The MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay described by Mossman (1983) Hayhoe and Quaglino (1988) . Briefly, cytospins were fixed with formalin vapor followed by consecutive incubations in periodic acid and Schiff's leucobasic fuchsin.
Antibodies
The following antibodies with indicated specificities were used: mAb XT2.1, anti Xenopus T cell (Nagata, 1985) ; mAb XL 1, anti Xenopus leukocyte (Ohinata et al., 1989) ; mAb AM20, anti Xenopus MHC class II (Flajnik et al., 1990); mAb 6.16, anti Xenopus IgM (Bleicher and Cohen, 1981) 
